Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-(+)-Benzyl glycidyl ether, also known as (S)-(+)-Glycidyl benzyl ether, is an aryl glycidyl ether that is colorless to light yellow in appearance. It is a valuable compound in the field of organic chemistry due to its ability to undergo stereospecific cyclizations, leading to the formation of 3-chromanols or tetrahydrobenzo[c]oxepin-4-ols. This enantiomerically pure compound has been synthesized with a 30%ee (enantiomeric excess) along with (R)-3-benzyloxypropane-1,2-diol with 40%ee, through its resolution using whole cells of Bacillus alcalophilus.

16495-13-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 16495-13-9 Structure
  • Basic information

    1. Product Name: (S)-(+)-Benzyl glycidyl ether
    2. Synonyms: (s)-o-benzylglycidol;(S)-(+)-2-(BENZYLOXYMETHYL)OXIRANE;(S)-(+)-1-BENZYLOXY-2,3-EPOXYPROPANE;(S)-1-BENZYLOXY-2,3-EPOXYPROPANE;(S)-(+)-BENZYL GLYCIDYL ETHER;(S)-BENZYL GLYCIDYL ETHER;(S)-BENZYLOXYMETHYL-OXIRANE;(+)-BENZYL (S)-GLYCIDYL ETHER
    3. CAS NO:16495-13-9
    4. Molecular Formula: C10H12O2
    5. Molecular Weight: 164.2
    6. EINECS: -0
    7. Product Categories: chiral;CHIRAL COMPOUNDS;Chiral Building Blocks;Glycidyl Compounds, etc. (Chiral);Oxiranes;Simple 3-Membered Ring Compounds;Synthetic Organic Chemistry;Chiral Compound
    8. Mol File: 16495-13-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 130 °C (0.1 mmHg)
    3. Flash Point: >110°C
    4. Appearance: Colorless to light yellow liquid
    5. Density: 1.072 g/mL at 20 °C(lit.)
    6. Refractive Index: n20/D 1.517
    7. Storage Temp.: 2-8°C
    8. Solubility: Chloroform, Ethanol
    9. BRN: 5246495
    10. CAS DataBase Reference: (S)-(+)-Benzyl glycidyl ether(CAS DataBase Reference)
    11. NIST Chemistry Reference: (S)-(+)-Benzyl glycidyl ether(16495-13-9)
    12. EPA Substance Registry System: (S)-(+)-Benzyl glycidyl ether(16495-13-9)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36-37/39
    4. WGK Germany: 3
    5. RTECS: TX2860030
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 16495-13-9(Hazardous Substances Data)

16495-13-9 Usage

Uses

1. Used in Pharmaceutical Synthesis:
(S)-(+)-Benzyl glycidyl ether is used as a reactant in the synthesis of (+)-Discodermolide, a natural product with potential pharmaceutical applications. It serves as a key intermediate in the production of this compound, highlighting its importance in the development of new drugs.
2. Used in Total Asymmetric Synthesis:
(S)-(+)-Benzyl glycidyl ether may be employed for the total asymmetric synthesis of (+)-gigantecin, another biologically active compound with potential applications in the pharmaceutical industry. Its use in this process demonstrates its versatility and utility in the synthesis of complex organic molecules.
3. Used in Organic Chemistry Research:
As an aryl glycidyl ether, (S)-(+)-Benzyl glycidyl ether is used in various research applications to study the stereochemistry and reactivity of these types of compounds. Its ability to undergo stereospecific cyclizations makes it a valuable tool for understanding the underlying mechanisms and developing new synthetic strategies in organic chemistry.

Safety Profile

Mutation data reported. Whenheated to decomposition it emits acrid smoke andirritating vapors.

Check Digit Verification of cas no

The CAS Registry Mumber 16495-13-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,4,9 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 16495-13:
(7*1)+(6*6)+(5*4)+(4*9)+(3*5)+(2*1)+(1*3)=119
119 % 10 = 9
So 16495-13-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O2/c1-2-4-9(5-3-1)6-11-7-10-8-12-10/h1-5,10H,6-8H2/t10-/m1/s1

16495-13-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B2239)  Benzyl (S)-(+)-Glycidyl Ether  >98.0%(GC)

  • 16495-13-9

  • 1g

  • 390.00CNY

  • Detail
  • TCI America

  • (B2239)  Benzyl (S)-(+)-Glycidyl Ether  >98.0%(GC)

  • 16495-13-9

  • 5g

  • 1,250.00CNY

  • Detail
  • TCI America

  • (B2239)  Benzyl (S)-(+)-Glycidyl Ether  >98.0%(GC)

  • 16495-13-9

  • 25g

  • 4,500.00CNY

  • Detail
  • Alfa Aesar

  • (L14033)  Benzyl (S)-(+)-glycidyl ether, 98+%   

  • 16495-13-9

  • 1g

  • 400.0CNY

  • Detail
  • Alfa Aesar

  • (L14033)  Benzyl (S)-(+)-glycidyl ether, 98+%   

  • 16495-13-9

  • 5g

  • 1763.0CNY

  • Detail
  • Aldrich

  • (363537)  (S)-(+)-Glycidylbenzylether  99%

  • 16495-13-9

  • 363537-1G

  • 380.25CNY

  • Detail

16495-13-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-(+)-Benzyl glycidyl ether

1.2 Other means of identification

Product number -
Other names (S)-(+)-1-Benzyloxy-2,3-epoxypropane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16495-13-9 SDS

16495-13-9Relevant articles and documents

Diastereoselective Alkene Hydroesterification Enabling the Synthesis of Chiral Fused Bicyclic Lactones

Shi, Zhanglin,Shen, Chaoren,Dong, Kaiwu

supporting information, p. 18039 - 18042 (2021/11/16)

Palladium-catalysed diastereoselective hydroesterification of alkenes assisted by the coordinative hydroxyl group in the substrate afforded a variety of chiral γ-butyrolactones bearing two stereocenters. Employing the carbonylation-lactonization products as the key intermediates, the route from the alkenes with single chiral center to chiral THF-fused bicyclic γ-lactones containing three stereocenters was developed.

A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration

González-Gil, Inés,Zian, Debora,Vázquez-Villa, Henar,Hernández-Torres, Gloria,Martínez, R. Fernando,Khiar-Fernández, Nora,Rivera, Richard,Kihara, Yasuyuki,Devesa, Isabel,Mathivanan, Sakthikumar,Del Valle, Cristina Rosell,Zambrana-Infantes, Emma,Puigdomenech, María,Cincilla, Giovanni,Sanchez-Martinez, Melchor,Rodríguez De Fonseca, Fernando,Ferrer-Montiel, Antonio V.,Chun, Jerold,López-Vales, Rubén,López-Rodríguez, María L.,Ortega-Gutiérrez, Silvia

supporting information, p. 2372 - 2390 (2020/01/02)

Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need to develop more efficacious NP attenuating drugs. Activation of the type 1 lysophosphatidic acid (LPA1) receptor is a crucial factor in the initiation of NP. Hence, it is conceivable that a functional antagonism strategy could lead to NP mitigation. Here we describe a new series of LPA1 agonists among which derivative (S)-17 (UCM-05194) stands out as the most potent and selective LPA1 receptor agonist described so far (Emax = 118%, EC50 = 0.24 μM, KD = 19.6 nM; inactive at autotaxin and LPA2-6 receptors). This compound induces characteristic LPA1-mediated cellular effects and prompts the internalization of the receptor leading to its functional inactivation in primary sensory neurons and to an efficacious attenuation of the pain perception in an in vivo model of NP.

Stereoselective total synthesis of (?)-galantinic acid and 1-deoxy-5-hydroxysphingolipids via prins cyclization

Rahman, Md. Ataur,Haque, Ashanul,Yadav, Jhillu Singh

, (2020/07/03)

The stereoselective total synthesis of (?)-galantinic acid 1 and 1-deoxy-5-hydroxysphingolipids 4 is described via Prins cyclization protocol followed by reductive ring opening sequence of substituted pyrenol derivative 6. The target molecules were synthesized using a common synthetic intermediate epoxide 5. Besides, we also proposed synthetic pathways to achieve other structural analogues using common intermediates.

Improving the activity and enantioselectivity of PvEH1, a Phaseolus vulgaris epoxide hydrolase, for o-methylphenyl glycidyl ether by multiple site-directed mutagenesis on the basis of rational design

Li, Chuang,Kan, Ting-Ting,Hu, Die,Wang, Ting-Ting,Su, Yong-Jun,Zhang, Chen,Cheng, Jian-Qing,Wu, Min-Chen

, (2019/08/01)

Substrate spectrum assay exhibited that PvEH1, which is an epoxide hydrolase from P. vulgaris, had the highest specific activity and enantiomeric ratio (E) for racemic o-methylphenyl glycidyl ether (rac-1) among tested aryl glycidyl ethers (1–5). To produce (R)-1 via kinetic resolution of rac-1 efficiently, the catalytic properties of PvEH1 were further improved on the basis of rational design. Firstly, the seven single-site variants of PvEH1-encoding gene (pveh1) were PCR-amplified as designed, and expressed in E. coli BL21(DE3). Among all expressed single-site mutants, PvEH1L105I and PvEH1V106I had the highest specific activities of 17.6 and 16.4 U/mg protein, respectively, while PvEH1L196D had an enhanced E value of 9.2. Secondly, to combine their respective merits, one triple-site variant, pveh1L105I/V106I/L196D, was also amplified, and expressed. The specific activity, E value, and catalytic efficiency of PvEH1L105I/V106I/L196D were 23.1 U/mg, 10.9, and 6.65 mM?1 s?1, respectively, which were 2.0-, 1.8- and 2.4-fold higher than those of wild-type PvEH1. The source of PvEH1L105I/V106I/L196D with enhanced E value for rac-1 was preliminarily analyzed by molecular docking simulation. Finally, the scale-up kinetic resolution of 100 mM rac-1 was conducted using 5 mg wet cells/mL E. coli/pveh1L105I/V106I/L196D at 25 °C for 1.5 h, producing (R)-1 with 95.0% ees, 32.1% yield and 3.52 g/L/h space-time yield.

Chiral Bifunctional Metalloporphyrin Catalysts for Kinetic Resolution of Epoxides with Carbon Dioxide

Maeda, Chihiro,Mitsuzane, Mayato,Ema, Tadashi

supporting information, p. 1853 - 1856 (2019/03/11)

Chiral binaphthyl-strapped Zn(II) porphyrins with triazolium halide units were synthesized as bifunctional catalysts for kinetic resolution of epoxides with CO2. Several catalysts were screened by changing the linker length and nucleophilic counteranions, and the optimized catalyst accelerated the enantioselective reaction at ambient temperature to produce optically active cyclic carbonates and epoxides.

Asymmetric Hydrolytic and Aminolytic Kinetic Resolution of Racemic Epoxides using Recyclable Macrocyclic Chiral Cobalt(III) Salen Complexes

Tak, Rajkumar,Kumar, Manish,Menapara, Tusharkumar,Gupta, Naveen,Kureshy, Rukhsana I.,Khan, Noor-ul H.,Suresh

supporting information, p. 3990 - 4001 (2017/11/22)

New chiral macrocyclic cobalt(III) salen complexes were synthesized and used as catalyst for the asymmetric kinetic resolution (AKR) of terminal epoxides and glycidyl ethers with aromatic/aliphatic amines and water as nucleophiles. This is the first occasion where a Co(III) salen complex demonstrated its ability to catalyze AKR as well as hydrolytic kinetic resolution (HKR) reactions. Excellent enantiomeric excesses of the epoxides, the corresponding amino alcohols and diols (upto 99%) with quantitative yields were achieved by using the chiral Co(III) salen complexes in dichloromethane at room temperature. This protocol was further extended for the synthesis of two important drug molecules, i.e., (S)-propranolol and (R)-naftopidil. The catalytic system was also explored for the synthesis of chirally pure diols and chiral cyclic carbonates using carbon dioxide as a greener renewable C1 source. The catalyst was recycled for upto 5 catalytic cycles with retention of enantioselectivity. (Figure presented.).

Effect of Partially Fluorinated N-Alkyl-Substituted Piperidine-2-carboxamides on Pharmacologically Relevant Properties

Vorberg, Raffael,Trapp, Nils,Zimmerli, Daniel,Wagner, Bj?rn,Fischer, Holger,Kratochwil, Nicole A.,Kansy, Manfred,Carreira, Erick M.,Müller, Klaus

, p. 2216 - 2239 (2016/10/19)

The modulation of pharmacologically relevant properties of N-alkyl-piperidine-2-carboxamides was studied by selective introduction of 1–3 fluorine atoms into the n-propyl and n-butyl side chains of the local anesthetics ropivacaine and levobupivacaine. The basicity modulation by nearby fluorine substituents is essentially additive and exhibits an exponential attenuation as a function of topological distance between fluorine and the basic center. The intrinsic lipophilicity of the neutral piperidine derivatives displays the characteristic response noted for partially fluorinated alkyl groups attached to neutral heteroaryl systems. However, basicity decrease by nearby fluorine substituents affects lipophilicities at neutral pH, so that all partially fluorinated derivatives are of similar or higher lipophilicity than their non-fluorinated parents. Aqueous solubilities were found to correlate inversely with lipophilicity with a significant contribution from crystal packing energies, as indicated by variations in melting point temperatures. All fluorinated derivatives were found to be somewhat more readily oxidized in human liver microsomes, the rates of degradation correlating with increasing lipophilicity. Because the piperidine-2-carboxamide core is chiral, pairs with enantiomeric N-alkyl groups are diastereomeric. While little response to such stereoisomerism was observed for basicity or lipophilicity, more pronounced variations were observed for melting point temperatures and oxidative degradation.

Substrate stereocontrol in bromine-induced intermolecular cyclization: Asymmetric synthesis of pitavastatin calcium

Chen, Weiqi,Xiong, Fangjun,Liu, Qian,Xu, Lingjun,Wu, Yan,Chen, Fener

, p. 4730 - 4737 (2015/07/27)

A novel approach to synthesize pitavastatin calcium (1), an effective HMG-CoA reductase inhibitor, based on readily available and attractively functionalized (R)-3-chloro-1,2-propanediol is reported. This work highlights an intermolecular diastereoselective bromine-induced cyclization of homoallylic carbonate to meet stereochemical challenges in the synthesis of statins. An efficient route to a new triphenylphosphonium tetrafluoroborate salt of a quinoline core is also presented.

A new enantioselective synthesis of (S)-2-ethoxy-3-(4-hydroxyphenyl) propanoic acid esters (EEHP and IEHP), useful pharmaceutical intermediates of PPAR agonists

Mujahid,Kunte,Muthukrishnan

supporting information, p. 3223 - 3226 (2014/06/09)

A new enantioselective synthetic route to the title compounds has been developed in a simple and practical way with high enantiopurity using commercially available starting material.

Asymmetric hydrolytic kinetic resolution with recyclable polymeric Co(iii)-salen complexes: A practical strategy in the preparation of (S)-metoprolol, (S)-toliprolol and (S)-alprenolol: Computational rationale for enantioselectivity

Roy, Tamal,Barik, Sunirmal,Kumar, Manish,Kureshy, Rukhsana I.,Ganguly, Bishwajit,Khan, Noor-Ul H.,Abdi, Sayed H. R.,Bajaj, Hari C.

, p. 3899 - 3908 (2015/02/19)

A series of chiral polymeric Co(iii)-salen complexes based on a number of achiral and chiral linkers were synthesized and their catalytic performances were assessed in the asymmetric hydrolytic kinetic resolution of terminal epoxides. The effects of the linker were judiciously studied and it was found that in the case of the chiral BINOL-based polymeric salen complex 1, there was an enrichment in catalyst reactivity and enantioselectivity of the unreacted epoxide, particularly in the case of short as well as long chain aliphatic epoxides. Good isolated yields of the unreacted epoxide (up to 46% compared to 50% theoretical yield) along with high enantioselectivity (up to 99%) were obtained in most cases using catalyst 1. Further studies showed that catalyst 1 could retain its catalytic activity for six cycles under the present reaction conditions without any significant loss in activity or enantioselectivity. To show the practical applicability of the above synthesized catalyst we have synthesised some potent chiral β-blockers in moderate yield and high enantioselectivity using complex 1. The DFT (M06-L/6-31+G??//ONIOM(B3LYP/6-31G?:STO-3G)) calculations revealed that the chiral BINOL linker influences the enantioselectivity achieved with Co(iii)-salen complexes. Further, the transition state calculations show that the R-BINOL linker with the (S,S)-Co(iii)-salen complex is energetically preferred over the corresponding S-BINOL linker with the (S,S)-Co(iii)-salen complex for the HKR of 1,2-epoxyhexane. The role of non-covalent C-H?π interactions and steric effects has been discussed to control the HKR reaction of 1,2-epoxyhexane.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16495-13-9